BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31153713)

  • 1. Variation in a novel antipseudomonal antimicrobial consumption metric across hospital inpatient units at a Veterans Affairs hospital: A retrospective cohort study.
    Vissichelli NC; Bailey P; Sabo RT; Tassone D; Vaughan L; Stevens MP; Markley JD
    Am J Infect Control; 2019 Oct; 47(10):1263-1264. PubMed ID: 31153713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a Novel Antipseudomonal Antibiotic Consumption Metric Among Academic Medical Centers in the United States.
    Markley JD; Pakyz AL; Sabo RT; Bearman G; Hohmann SF; Stevens MP
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):229-232. PubMed ID: 29331155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia.
    McDougall DA; Morton AP; Playford EG
    J Antimicrob Chemother; 2013 Feb; 68(2):457-60. PubMed ID: 23027714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study.
    Smoke S; Raja K; Narayanan N; Brunetti L
    Int J Antimicrob Agents; 2019 Sep; 54(3):367-370. PubMed ID: 31202924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.
    Abbara S; Domenech de Cellès M; Batista R; Mira JP; Poyart C; Poupet H; Casetta A; Kernéis S
    J Hosp Infect; 2020 Feb; 104(2):150-157. PubMed ID: 31605739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.
    Horikoshi Y; Higuchi H; Suwa J; Isogai M; Shoji T; Ito K
    J Infect Chemother; 2016 Aug; 22(8):532-5. PubMed ID: 27263807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
    Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
    J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals.
    Eagye KJ; Nicolau DP
    Infect Control Hosp Epidemiol; 2010 May; 31(5):485-90. PubMed ID: 20334550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently needed.
    Zhang D; Cui K; Lu W; Bai H; Zhai Y; Hu S; Li H; Dong H; Feng W; Dong Y
    Antimicrob Resist Infect Control; 2019; 8():5. PubMed ID: 30627429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combination Antibiogram Evaluation for
    Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of formulary restriction on the relative consumption of carbapenems in intensive care units at an academic medical center.
    Pierce JW; Kirk A; Lee KB; Markley JD; Pakyz A; Bearman G; Doll ME; Stevens MP
    Infect Control Hosp Epidemiol; 2019 Sep; 40(9):1056-1058. PubMed ID: 31232265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of peer comparison on carbapenem use among inpatient prescribers at a community hospital.
    Rosa RM; Bushman AM
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):376-378. PubMed ID: 31948502
    [No Abstract]   [Full Text] [Related]  

  • 14. Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem.
    Eagye KJ; Nicolau DP
    J Antimicrob Chemother; 2011 Jun; 66(6):1392-5. PubMed ID: 21459897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
    Zou Y; Lian J; Di Y; You H; Yao H; Liu J; Dong Y
    Int J Clin Pharm; 2018 Feb; 40(1):175-182. PubMed ID: 29134489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Implementation of a Hospital-wide Practice for the Selective Use of Carbapenems Based on the Monitoring of Susceptibility of Pseudomonas aeruginosa Isolates.
    Ohshima T; Asai S; Miyazawa M; Yamamoto Y; Hisada A; Kumazawa C; Hashimoto M; Fukawa K; Iwashita H; Umezawa K; Yamada S; Yamamoto Y; Miyachi H
    Tokai J Exp Clin Med; 2017 Dec; 42(4):176-181. PubMed ID: 29228415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
    Nicolau DP; Carmeli Y; Crank CW; Goff DA; Graber CJ; Lima AL; Goldstein EJ
    Int J Antimicrob Agents; 2012 Jan; 39(1):11-5. PubMed ID: 22047702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
    Mladenovic-Antic S; Kocic B; Velickovic-Radovanovic R; Dinic M; Petrovic J; Randjelovic G; Mitic R
    J Clin Pharm Ther; 2016 Oct; 41(5):532-7. PubMed ID: 27511808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.